Christine Shaw, VP, Assay Development

GNMK 79,999 shares

The estimated Net Worth of Christine Shaw is at least $1,131,185.86. Christine Shaw owns over 79,999 units of GenMark Diagnostics, Inc. stock worth over $1,131,185.86.

Transaction DateCompanySharesTypeOwnedPriceValuePost Value
25th August 2020GNMK - GenMark Diagnostics, Inc.379Open or private sale79,999$14.14$5,359.06$1,131,185.86
8th September 2020GNMK - GenMark Diagnostics, Inc.285Open or private sale79,714$11.02$3,140.70$878,448.28